Gen9, Inc.

CAMBRIDGE, MA · Founded 2009 · Medtech · Acquired

Healthcare technology and diagnostic systems adapted from defense and nuclear arsenal testing methodologies

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · gen9.com

Sector: Medtech
Headquarters: CAMBRIDGE, MA
Founded: 2009
Latest Form D: $25M, Jul 2014
Total capital: $57.1M

Federal grants: $7M; 8 awards · 2015–2023; 8.0× sector median 1 award
Private capital raised: $50.1M; 6 Form D · last Jul 2014; 147 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 20; 20 pending · first 2018; Rank in peer group#6 of 42

Capital timeline

Latest events

Jul 2023Federal grantHealth and Human S · Phase II · Auracle: An AI-Enabled Telecare System to Support the Independence and Safety of Individuals with AD/ADRD and Other Dementias$1.1M
Sep 2022Federal grantHealth and Human S · Phase II · Auracle: An AI-Enabled Telecare System to Support the Independence and Safety of Individuals with AD/ADRD and Other Dementias$1.3M
Sep 2021Federal grantHealth and Human S · Phase II · Auracle: An AI-Enabled Telecare System to Support the Independence and Safety of Individuals with AD/ADRD and Other Dementias$446K
Jul 2020Federal grantHealth and Human S · Phase II · Phase IIB - Smart Eyewear Assistant for the Support of Seniors and their Caregivers in the Long-term Care Setting$888K
Jul 2019Federal grantHealth and Human S · Phase II · Phase IIB - Smart Eyewear Assistant for the Support of Seniors and their Caregivers in the Long-term Care Setting$994K
Jul 2018Federal grantHealth and Human S · Phase II · Phase IIB - Smart Eyewear Assistant for the Support of Seniors and their Caregivers in the Long-term Care Setting$996K
Jul 2016Federal grantHealth and Human S · Phase II · Head-mounted Activity Monitoring(HAM)System Fast Track$456K
Jul 2014Private capital raisedForm D · SEC · 6th filing$25M
May 2013Private capital raisedForm D · SEC · 5th filing$21M
May 2012Private capital raisedForm D · SEC · 4th filing$395K
Sep 2011Private capital raisedForm D · SEC · 3rd filing$1.6M
Feb 2011Private capital raisedForm D · SEC · 2nd filing$1.7M
Jun 2009Private capital raisedForm D · SEC · 1st filing$500K

Show 1 earlier federal award

Jul 2015Federal grantHealth and Human S · Phase II · Head-mounted Activity Monitoring(HAM)System Fast Track$846K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 42 peers

Line = median

Medtech · System

Granted patents#6 · top 14%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Joseph JacobsonResearcherDirector, PromoterLinked by 5 patents
Aaron ZuckerExecutive OfficerNamed in SEC Form D filings
Bill ScalzulliDirectorNamed in SEC Form D filings
David StoneExecutive OfficerNamed in SEC Form D filings
Drew EndyDirectorNamed in SEC Form D filings
Franco CerrinaDirector, Executive OfficerNamed in SEC Form D filings

Show all 22 people

George ChurchDirectorNamed in SEC Form D filings
Jacob ThaysenDirectorNamed in SEC Form D filings
James HollenhorstDirectorNamed in SEC Form D filings
Jennifer CamachoExecutive OfficerNamed in SEC Form D filings
Jeremy WertheimerDirectorNamed in SEC Form D filings
Jim HollenhorstDirectorNamed in SEC Form D filings
Kevin MunnellyExecutive Officer, DirectorNamed in SEC Form D filings
Lawrence SilversteinExecutive OfficerNamed in SEC Form D filings
Martin GoldbergExecutive OfficerNamed in SEC Form D filings
Neil CookDirectorNamed in SEC Form D filings
Paul ManningDirectorNamed in SEC Form D filings
Scott SchoenDirectorNamed in SEC Form D filings
Stanley RoseDirectorNamed in SEC Form D filings
Stephen JurvetsonDirectorNamed in SEC Form D filings
Wali DaiDirectorNamed in SEC Form D filings
Weili DaiDirectorNamed in SEC Form D filings

What it has protected

USPTO · 20 granted of 40

Mar 4, 2025GrantedMethods For Nucleic Acid Assembly And High Throughput SequencingUSPTOUS 12,241,057
Dec 21, 2023PendingCompositions And Methods For High Fidelity Assembly Of Nucleic AcidsUSPTOApplication 18324339
Dec 19, 2023GrantedMethods And Devices For Nucleic Acids SynthesisUSPTOUS 11,845,054

Show all 40 patent records

Methods For Nucleic Acid Assembly And High Throughput SequencingMar 4, 2025 · US 12,241,057Granted
Compositions And Methods For High Fidelity Assembly Of Nucleic AcidsDec 21, 2023 · Application 18324339Pending
Methods And Devices For Nucleic Acids SynthesisDec 19, 2023 · US 11,845,054Granted
Compositions And Methods For High Fidelity Assembly Of Nucleic AcidsJul 18, 2023 · US 11,702,662Granted
Methods For The Production Of Long Length Clonal Sequence Verified Nucleic Acid ConstructsOct 20, 2022 · Application 17532065Pending
Methods For Preparative In Vitro CloningMay 26, 2022 · Application 17536828Pending
Compositions, Methods And Apparatus For Oligonucleotides SynthesisFeb 8, 2022 · US 11,242,523Granted
Compositions And Methods For Multiplex Nucleic Acids SynthesisSep 28, 2021 · US 11,130,948Granted
Assembly Of High Fidelity PolynucleotidesSep 23, 2021 · Application 17341286Pending
Methods And Devices For High Fidelity Polynucleotide SynthesisAug 19, 2021 · Application 17242178Pending
Methods And Devices For Nucleic Acids SynthesisAug 10, 2021 · US 11,084,014Granted
Methods For Nucleic Acid Assembly And High Throughput SequencingJul 27, 2021 · US 11,072,789Granted
Assembly Of High Fidelity PolynucleotidesJul 27, 2021 · US 11,071,963Granted
Protein Arrays And Methods Of Using And Making The SameJul 8, 2021 · Application 17202311Pending
Methods And Devices For High Fidelity Polynucleotide SynthesisMay 25, 2021 · US 11,015,191Granted
Methods For Sorting Nucleic Acids And Multiplexed Preparative In Vitro CloningMay 13, 2021 · Application 17152202Pending
Protein Arrays And Methods Of Using And Making The SameApr 20, 2021 · US 10,982,208Granted
Microarray Synthesis And Assembly Of Gene-length PolynucleotidesMar 4, 2021 · Application 17019448Pending
Methods For Sorting Nucleic Acids And Multiplexed Preparative In Vitro CloningFeb 23, 2021 · US 10,927,369Granted
Libraries Of Nucleic Acids And Methods For Making The SameFeb 11, 2021 · Application 17083033Pending
Methods And Apparatuses For Chip-based Dna Error ReductionJan 14, 2021 · Application 17033017Pending
Methods and Apparatuses for Chip-Based DNA Error ReductionNov 10, 2020 · US 10,829,759Granted
Microarray Synthesis And Assembly Of Gene-length PolynucleotidesSep 15, 2020 · US 10,774,325Granted
Iterative Nucleic Acid Assembly Using Activation Of Vector-encoded TraitsJul 23, 2020 · Application 16224444Pending
Compositions And Methods For Site-directed Dna Nicking And CleavingJun 11, 2020 · Application 16713529Pending
Microarray Synthesis and Assembly of Gene-Length PolynucleotidesMay 5, 2020 · US 10,640,764Granted
Device And Method For Nucleic Acid ManipulationMar 26, 2020 · Application 16615914Pending
Methods For Nucleotide Sequencing And High Fidelity Polynucleotide SynthesisOct 24, 2019 · Application 16268258Pending
Microarray Synthesis And Assembly Of Gene-length PolynucleotidesOct 22, 2019 · US 10,450,560Granted
Methods For Screening Proteins Using Dna Encoded Chemical Libraries As Templates For Enzyme CatalysisAug 15, 2019 · Application 16397314Pending
Methods for Screening Proteins Using DNA Encoded Chemical Libraries as Templates for Enzyme CatalysisJun 4, 2019 · US 10,308,931Granted
Methods And Microfluidic Devices For The Manipulation Of Droplets In High Fidelity Polynucleotide AssemblyMay 16, 2019 · Application 16231117Pending
Compositions, Methods and Apparatus for Oligonucleotides SynthesisMay 7, 2019 · US 10,280,417Granted
Compositions and Methods for Multiplex Nucleic Acids SynthesisApr 30, 2019 · US 10,273,471Granted
Methods And Compositions For Nucleic Acid AssemblyJan 10, 2019 · Application 16064044Pending
Compositions And Methods For Synthesis Of High Fidelity OligonucleotidesJan 10, 2019 · Application 16039233Pending
Transcription Terminator And Use ThereofDec 13, 2018 · Application 15779902Pending
Methods for sorting nucleic acids and multiplexed preparative in vitro cloningSep 25, 2018 · US 10,081,807Granted
Microfluidic Devices And Methods For Gene SynthesisSep 20, 2018 · Application 15977885Pending
Compositions and Methods for Synthesis of High Fidelity OligonucleotidesAug 21, 2018 · US 10,053,719Granted

Dragon Vascular, Inc.Similar federal contract value in Medtech · null in contracts
BIOTRICITY INC.Similar federal contract value in Medtech · null in contracts
Eyas Medical Imaging, Inc.Similar federal contract value in Medtech · null in contracts
STRATEOS SUB, INC.Similar federal contract value in Medtech · null in contracts
Rampart IC, Inc.Similar federal contract value in Medtech · null in contracts
Phantom Neuro Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.